Health Trials

Therapeutic Recommendations for Nephroblastoma

ConditionNephroblastoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorFrench Africa Pediatric Oncology Group

About this trial

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Data collection

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

7
Burkina Faso
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle Ouagadougou Burkina Faso
Côte d’Ivoire
CHU de Treichville à ABIDJAN AbidjanAbidjan Autonomous District, Côte d’Ivoire
Democratic Republic of the Congo
CUK (Cliniques Universitaires de Kinshasa)BP 12 KIN XI, Kinshasa Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)BP 1825, Lubumbashi Democratic Republic of the Congo

Sponsors and collaborators

French Africa Pediatric Oncology Group

Lead sponsor

Source ClinicalTrials.gov